Clinical Evaluation Of Bibhitaki Phala In Tamaka Shvasa
Tamak Shvasa is a major chronic respiratory disorders among five types of Shvasa Roga closely resembling Bronchial Asthma mentioned in Modern Medicine. Bibhitaki (Terminalia bellerica Roxb.) has been clearly indicated as single drug therapy in Shvasa roga in classical ayurvedic texts. Bibhitaki is well known for its Anti-allergic, Anti-inflammatory & Bronchodilator activity. An Open labelled controlled study was done on 90 patients (three groups of 30 patients each) at Ayurved Mahavidyalaya, Sion, Mumbai-22. Groups were labelled as A, B, C and were given Bibhitaki choorna, Tab Deriphylline and combination of both respectively for duration of 30 days.
Weekly assessment was done on the basis of symptoms i.e. Shvasa vega, Shvasa kashtata, Kantha ghurghurakama, Sashabda Shvasa, Kasa, Kapha Nishthivanama, Shleshma vimokshante muhurtam sukham, Urahshula, Peenasa, Griva shira sangraha. Objective assessment was done by assessing Peak Expiratory Flow Rate, Breath holding time, Respiratory rate, Chest expansion weekly and Eosinophil count & ESR at initial and then after 30 days. Statistical analysis was done by applying Wilcoxon Matched-Pairs Signed Ranks test to Subjective criteria and Anova test to Objective criteria at baseline and at the end of study. Percentage improvement in signs and symptoms was found to be 57.89%, 63.25% and 71.49% in Group A, B & C respectively. Wilcoxon Matched-Pairs Test was found to be significant at 1 % level of significance (p<0.001) and Anova test was found to be significant at 5 % level of significance (p<0.05).
Details: Written by Dr. Shrikant Hadole; Dr. Ashok Ramteke; Dr. Rajesh Iyer; Dr. Sonali Gandhi
Attachment: Download Attacment